Literature DB >> 15809737

Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.

Hua Kang1, Robert E Mansel, Wen G Jiang.   

Abstract

Stromal cell-derived factor-1 (SDF-1), via its receptor CXCR4, has been implicated in metastasis of cancer, including breast cancer. Exogenous SDF-1 is known to regulate locomotion, chemotaxis and adhesion. The knowledge regarding the effect of autocrine SDF-1 on breast cancer cells is not available. The current study evaluated the effects of SDF-1 on the biological behaviour of breast cancer cells by genetically modifying the expression of SDF-1 in breast cancer cells. Two human breast cancer cell lines (MDA-MB-231 and MDA-MB-435s) and a human fetal lung fibroblast cell line (MRC5) were used. The expression of SDF-1 and the SDF-1 receptor, CXCR4 in the cell lines were studied. Expression cassettes of human SDF-1 and hammerhead ribozyme transgenes specifically targeting human SDF-1 were constructed and used to over-express SDF-1 or to knockout the expression of SDF-1 in cancer cells, respectively. Invasiveness, migration and growth of the genetically modified cells were assessed. SDF-1 was expressed in wild-type human breast cancer cell line MDA-MB-435s and fibroblast cell line MRC5, but not in MDA-MB-231 cell line. In contrast, CXCR4 expression was observed in all three cell lines tested. The ability of invasion and migration was significantly reduced in SDF-1 knockout MDA-MB-435s cells, compared with wild-type and vector control cells (p<0.01). On the other hand, SDF-1 transfected MDA-MB-231epsilonSDF1+/+ cells that stably expressed SDF-1 showed a different behaviour from MDA-MB-231SDF1+/- (plasmid control) and wild-type MDA-MB-231 cells, both being SDF-1 negative. MDA-MB-231epsilonSDF1+/+ cells displayed a higher degree of invasiveness and migration, compared with wild-type and MDA-MB-231SDF+/- cells (p<0.01). Furthermore, SDF1-knockout MDA-MB-435s cells showed a slower growth rate over a 7-day period compared with the respective control and wild-type MDA-MB-435s cells. In contrast, the growth of the SDF-1 transfected MDA-MB-231SDF1+/+ cells was markedly enhanced when compared with wild-type and vector control cells. Breast cancer cell lines, when equipped with the autocrine SDF-1-CXCR4 signal pathway, display aggressive behaviour, including an increase in invasiveness, migration together with faster growth. SDF-1, together with its receptor CXCR4 may provide important information for predicting the aggressive nature and constitute important therapeutic targets in human breast cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15809737

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  21 in total

1.  Biomaterial-enabled delivery of SDF-1α at the ventral side of breast cancer cells reveals a crosstalk between cell receptors to promote the invasive phenotype.

Authors:  Xi Qiu Liu; Laure Fourel; Fabien Dalonneau; Rabia Sadir; Salome Leal; Hugues Lortat-Jacob; Marianne Weidenhaupt; Corinne Albiges-Rizo; Catherine Picart
Journal:  Biomaterials       Date:  2017-02-27       Impact factor: 12.479

2.  Chemokine (C-C motif) ligand 2 mediates the prometastatic effect of dysadherin in human breast cancer cells.

Authors:  Jeong-Seok Nam; Mi-Jin Kang; Adam M Suchar; Takeshi Shimamura; Ethan A Kohn; Aleksandra M Michalowska; V Craig Jordan; Setsuo Hirohashi; Lalage M Wakefield
Journal:  Cancer Res       Date:  2006-07-15       Impact factor: 12.701

Review 3.  Adhesion molecules and chemokines: the navigation system for circulating tumor (stem) cells to metastasize in an organ-specific manner.

Authors:  Thomas Dittmar; Christoph Heyder; Eva Gloria-Maercker; Wolfgang Hatzmann; Kurt S Zänker
Journal:  Clin Exp Metastasis       Date:  2007-09-08       Impact factor: 5.150

4.  Prenylation-deficient G protein gamma subunits disrupt GPCR signaling in the zebrafish.

Authors:  Timothy Mulligan; Heiko Blaser; Erez Raz; Steven A Farber
Journal:  Cell Signal       Date:  2009-09-26       Impact factor: 4.315

5.  SLITs suppress tumor growth in vivo by silencing Sdf1/Cxcr4 within breast epithelium.

Authors:  Rebecca Marlow; Phyllis Strickland; Ji Shin Lee; Xinyan Wu; Milana Pebenito; Mikhail Binnewies; Elizabeth K Le; Angel Moran; Hector Macias; Robert D Cardiff; Saraswati Sukumar; Lindsay Hinck
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

6.  Helper T cell epitope-mapping reveals MHC-peptide binding affinities that correlate with T helper cell responses to pneumococcal surface protein A.

Authors:  Rajesh Singh; Shailesh Singh; Praveen K Sharma; Udai P Singh; David E Briles; Susan K Hollingshead; James W Lillard
Journal:  PLoS One       Date:  2010-02-25       Impact factor: 3.240

Review 7.  Organ selectivity in metastasis: regulation by chemokines and their receptors.

Authors:  Adit Ben-Baruch
Journal:  Clin Exp Metastasis       Date:  2007-09-21       Impact factor: 5.150

8.  PDZ-RhoGEF is essential for CXCR4-driven breast tumor cell motility through spatial regulation of RhoA.

Authors:  Amanda P Struckhoff; Manish K Rana; Swapnil S Kher; Matt E Burow; Joseph L Hagan; Luis Del Valle; Rebecca A Worthylake
Journal:  J Cell Sci       Date:  2013-07-18       Impact factor: 5.285

9.  Progesterone modulates endothelial progenitor cell (EPC) viability through the CXCL12/CXCR4/PI3K/Akt signalling pathway.

Authors:  Peng Yu; Zhifei Zhang; Shengjie Li; Xiaolong Wen; Wei Quan; Qilong Tian; Jieli Chen; Jianning Zhang; Rongcai Jiang
Journal:  Cell Prolif       Date:  2016-01-27       Impact factor: 6.831

Review 10.  Chemokine receptor CXCR4-prognostic factor for gastrointestinal tumors.

Authors:  Carl C Schimanski; Peter R Galle; Markus Moehler
Journal:  World J Gastroenterol       Date:  2008-08-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.